Xilio Therapeutics Inc. Company Profile
NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Xilio Therapeutics at a glance
Xilio Therapeutics Inc. (NASDAQ: XLO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Xilio Therapeutics is led by Dr. Rene Russo BCPS, Pharm.D. and employs about 76 people. The company's shares have traded publicly since 2021.
At a market capitalization of $59.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001840233, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Xilio Therapeutics do?
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Xilio Therapeutics Inc.
- Ticker
- NASDAQ: XLO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Rene Russo BCPS, Pharm.D.
- Employees
- 76
- Headquarters
- 828 Winter Street, Waltham, MA, United States
- Phone
- 857 524 2466
- Website
- xiliotx.com
- IPO year
- 2021
- Market cap
- $59.29M
- SEC CIK
- 0001840233
Companies similar to Xilio Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RNXTRenovoRx Inc. | 1.28 | -3.76% | $57.77M | vs XLO |
| BOLDBoundless Bio Inc. | 2.53 | -1.94% | $57.55M | vs XLO |
| GOSSGossamer Bio Inc. | 9.31 | -5.77% | $56.94M | vs XLO |
| ATHEAlterity Therapeutics Limited ADR | 3.12 | +1.47% | $56.72M | vs XLO |
| TLPHTalphera Inc. | 1.08 | 0.00% | $56.06M | vs XLO |
| IBIOiBio Inc. | 0.871 | -5.33% | $56.01M | vs XLO |
| APLMApollomics Inc. Class A | 21.50 | -0.92% | $62.67M | vs XLO |
| MREOMereo BioPharma Group plc ADR | 0.3499 | -6.74% | $55.88M | vs XLO |